A new oral PCSK9 inhibitor, enlicitide, offers a daily pill option for lowering LDL-C, a key cardiovascular disease risk factor. A clinical trial showed a significant 58.2% LDL-C reduction in patients ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

Struggling with sleep? A major analysis of 30 trials reveals that this exercise form, practiced for less than 30 minutes ...

State Representative Erin Byrnes, D-Dearborn, introduced a bill to give the Board of Pharmacy the power to create a list of ...

A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Viral TikTok clips show influencers flaunting rapid weight loss transformations, tapping into the body image concerns that ...

A new proposed law designed to restrict a minor’s access to certain dietary supplements. Meanwhile, FOX 2 was contacted by ...

The days of browsing the aisles of the health food stores in search of a diet pill that may or may not work are dwindling ...